Company overview
BIOVECTRA is a global full-service CDMO specializing in small molecules, biologics, bioreagents, pDNA, and mRNA manufacturing for pharma and biotech. They provide end-to-end services from process development and cGMP production at kilo lab, pilot, and commercial scales to analytical testing and sterile fill-finish. Capabilities include microbial fermentation, synthetic chemistry, high potency containment, and lipid nanoparticle formulation, supporting projects from early clinical to commercial supply.
CDMO for Small Molecules & Biologics is listed in the NovaPharmaNews Supplier Hub as a CDMO & Manufacturing partner serving United States & Americas. Core focus areas include biovectra, cdmo, small molecules, biologics manufacturing, mrna production, microbial fermentation.
Industry categories: CDMO & Manufacturing. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.
Products and technologies associated with CDMO for Small Molecules & Biologics include Cdmo, Cro — relevant for pharmaceutical discovery, process development, and GMP manufacturing workflows.
Structured facts
- Website
- https://www.biovectra.com
- Categories
- CDMO & Manufacturing
- Markets served
- United States & Americas
- Keywords
- biovectra, cdmo, small molecules, biologics manufacturing, mrna production, microbial fermentation, api development, sterile fill-finish
Products & technologies
Therapeutic areas
Markets served
Industry categories
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Related suppliers in category
Frequently asked questions
- What manufacturing capabilities does BIOVECTRA offer?
- BIOVECTRA provides cGMP CDMO services for small molecules via synthetic chemistry and microbial fermentation, biologics including proteins, enzymes, peptides, pDNA, mRNA, and lipid nanoparticles, plus sterile fill-finish across kilo lab, pilot, and commercial scales.
- What regulatory support and compliance does BIOVECTRA provide?
- BIOVECTRA supports GMP and CMC requirements with phase-appropriate analytical testing, method development/validation, process characterization, validation support, and Quality by Design strategies for small molecule APIs and biologic drug substances.
- What geographies does BIOVECTRA serve?
- BIOVECTRA serves biotech and pharmaceutical companies primarily in North America and Europe, with global CDMO operations based in Canada offering unique mRNA and pDNA capabilities.
Related editorial coverage
- America's Innovation Engine: Small and Mid-Sized Biotechs Drive U.S. Clinical Trials, FDA Filings
- AI Citation Gap in CDMO Capacity: Pharmaceutical Manufacturing Examples and Insights
- CordenPharma Expands Production Capacity with New CDMO Deal
- Novartis Ends Contract with Porton: Legal Implications and Market Impact
- IPEC Excipient World Biologics Summit 2026: Recap
- Small Molecule vs Biologics in Oncology: Market Trends & FDA Insights 2024
Explore lab tools and QA/QC resources for R&D teams.
